Ninerafaxstat well-tolerated and safe for nonobstructive hypertrophic cardiomyopathy
The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with nonobstructive hypertrophic cardiomyopathy (HCM), ...
Apr 8, 2024
0
0